Viroclinics Biosciences' Financial Acquisition - II

Viroclinics Biosciences raised a round of funding on August 29, 2017. Investors include Parcom Capital.

Viroclinics Biosciences is a diagnostic and clinical trial operation service company providing diagnostic and preclinical studies along with drug development for prevention and treatment of virus infe…

Articles about Viroclinics Biosciences' Financial Acquisition - II: